Atlas Trials

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Clinical trial NCT02095743 · UNKNOWN

Trial details

NCT number
NCT02095743
Sponsor
Centre Henri Becquerel
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Early Stage Breast Carcinoma
Start date
2014-04-01
Primary completion
2018-12-01
Enrollment
256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.